NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001198

Registered date:20/06/2008

Cilostazol trial

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedperipheral arterial disease
Date of first enrollment2004/10/01
Target sample size80
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Aspirin 81-100mg/day Aspirin 81-100mg/day + cilostazol 200mg/day

Outcome(s)

Primary Outcometarget vessel revascularization
Secondary Outcomemajor adverse cardiovascular event, restenosis rate

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria1)PAD patients with intermittent claudication who had a de novo femoropopliteal disease without an inflow lesion (aortoiliac or common femoral lesion), with an outflow artery (below the knee arteries) with more than one vessel run-off, and with symptoms that were not improved by pharmacotherapy or exercise therapy 2) ankle-brachial index (ABI) of ≤ 0.9 3) a percentage stenosis diameter of ≥ 50% by visual estimate on angiography
Exclude criteriaprevious lower extremity bypass surgery, previous EVT in the femoropopliteal artery, acute onset limb ischemia, or severe lower extremity ischemic symptoms classified into Rutherford Category 4, 5 or 6, known bleeding diathesis, hepatic dysfunction, active gastrointestinal bleeding or peptic ulcer disease, intolerance to cilostazol, aspirin or ticlopidine, pregnant women and women of child-bearing potential, and major life-threatening illness.

Related Information

Contact

public contact
Name
Address 1-1 Kifune-machi Kokurakita-ku Kitakyusyu city Fukuoka Japan Japan
Telephone 093-921-2231
E-mail
Affiliation Kokura Memorial Hospital cardiology
scientific contact
Name Hiroyoshi Yokoi
Address 1-1 Kifune-machi Kokurakita-ku Kitakyusyu city Fukuoka Japan Japan
Telephone 093-921-2231
E-mail
Affiliation Kokura Memorial Hospital Cardiology